Dr. Kalayoglu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
704 Quince Orchard Rd
Suite 210
Gaithersburg, MD 20878- Is this information wrong?
Summary
- Engineered cell therapies for cancer and autoimmune, respiratory and inflammatory diseases
Education & Training
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 2001 - 2004
- University of Wisconsin School of Medicine & Public HealthClass of 2000
Certifications & Licensure
- MA State Medical License 2001 - 2026
Publications & Presentations
PubMed
- 15 citationsSafety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-rand...Volkan Granit, Michael Benatar, Metin Kurtoglu, Miloš D Miljković, Nizar Chahin, Gregory Sahagian, Marc H Feinberg, Adam Slansky, Tuan Vu, Christopher M Jewell, Michae...> ;The Lancet. Neurology. 2023 Jul 1
- 4 citationsInfection, inflammation and age-related macular degeneration.Murat V. Kalayoglu, Joan W. Miller> ;Clinical & Experimental Ophthalmology. 2007 Jan 1
- 64 citationsIdentification of Chlamydia pneumoniae within human choroidal neovascular membranes secondary to age-related macular degenerationMurat V. Kalayoglu, Deisy V. Bula, Jorge G. Arroyo, Evangelos S. Gragoudas, Donald J. D'Amico, Joan W. Miller> ;Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2005 May 21
- Join now to see all
Press Mentions
- Dr. Murat Kalayoglu, President & CEO, Cartesian Therapeutics: The Leader in RNA Cell TherapyMay 31st, 2022
- Cartesian Therapeutics Doses Patient with First Allogeneic RNA Cell Therapy for Multiple MyelomaJanuary 25th, 2022
- Cartesian Therapeutics Strengthens Leadership Team with Hire of Miloš Miljković, M.D., as Chief Medical OfficerSeptember 28th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: